- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 26.02. | Alopexx seeks $11M IPO to advance ex-Sanofi infectious disease drug | ||
| 26.02. | Eikon remains in megaround mode with $350M series D to fund cancer trials | ||
| 26.02. | With no buyer for Tryvio, Idorsia claws back $100M from a double-asset deal with Viatris | ||
| 26.02. | AstraZeneca, eyeing $5B peak sales, reports phase 3 breast cancer win for oral SERD | ||
| 26.02. | Harbour offshoot pens $395M biobucks deal for preclinical rival to Neurocrine's Crenessity | ||
| 25.02. | Tandem Diabetes Care insulin-dosing algorithm nets FDA clearance for Type 2 diabetes | ||
| 25.02. | Emalex dopamine blocker stops Tourette syndrome relapse in phase 3 win | ||
| 25.02. | FDA updates Boston Scientific's Accolade pacemaker recall, reporting 832 injuries | ||
| 25.02. | Kiniksa adds to Sjögren's exodus with trial termination, axes AstraZeneca asset | ||
| 25.02. | Polish biotech Ryvu waves goodbye to 30% of staff in focus on phase 3 blood cancer trials | ||
| 25.02. | Lava, smoldering from dropping lead asset, lays off 30% of staff to save cash | ||
| 25.02. | Repare unveils scale of layoffs with 75% of staff and chief medical officer heading for exit | ||
| 25.02. | BioCity's ETA antagonist reduces proteinuria in phase 2 trial of diabetic kidney disease | ||
| 24.02. | Antibodies stop tissue damage and reduce virus levels in mice with deadly Crimean-Congo hemorrhagic fever | ||
| 24.02. | Regeneron gene therapy improves hearing in 10 children with rare form of hearing loss | ||
| 24.02. | FDA works to reverse layoffs, rehire lost staff: reports | ||
| 24.02. | Entrada's 2-year ordeal ends as FDA lifts hold on DMD drug | ||
| 24.02. | Ex-CDER chief Patrizia Cavazzoni becomes Pfizer's chief medical officer | ||
| 24.02. | FDA approves Medtronic's adaptive deep-brain stimulator for Parkinson's disease | ||
| 24.02. | OS Therapies sets up subsidiary to seek ADC joint ventures with US, China peers | ||
| 24.02. | Pfizer inks deal to test Summit's white-hot bispecific with ADCs | ||
| 24.02. | Sanofi shows how $500M bowel disease bet compares to Merck and Roche's rival assets | ||
| 24.02. | VC firm Kineticos launches biotech to develop fresh approach to antibiotic resistance | ||
| 21.02. | Deputy director of FDA's CBER departs amid mass exodus at federal health agencies | ||
| 21.02. | Roche rolls out new DNA 'sequencing-by-expansion' approach |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
